Clinical trial design, clinical advice to patients, and clinical decision-making: not the same thing at all

In a recent opinion piece in the Journal of Clinical Oncology, Dr. Anthony D’Amico (a prostate cancer specialist for whom we have great respect) has again aired his concerns about risk for progression to metastatic disease among men on active surveillance. … READ MORE …

What’s good for the patient is not always what they want

The following article was originally published in the ASCO Connection magazine on February 22, 2017 (click here for the original). It was written by Anne Katz, RN, PhD, FAAN, … READ MORE …

Conference call/webinar on bipolar androgen therapy (BAT)

For those who are interested, the Answer Cancer Foundation has let us know that they will be holding an educational conference call/webinar at 8:00 pm Eastern (5:00 pm Pacific) today on the subject of bipolar androgen therapy in the treatment of advanced prostate cancer. … READ MORE …

What everyone needs to expect about recovery post-surgery

Slowly but surely we are seeing increasing recognition in the clinical community of the need to ensure that prostate cancer patients and their spouses/partners really understand the likely consequences of treatment. … READ MORE …

The role of educational technology-based information in prostate cancer patient education

Unsurprisingly, your sitemaster’s interest was piqued by a paper in BMC Health Services Research on the use of patient educational technology (PET) as a core component of their clinical practice in prostate cancer management by two urology practices in Calgary, Canada. … READ MORE …

The NCCN patient guidelines have “come of age”

Over the past weekend, we were able to review the most recent update to the National Comprehensive Cancer Network’s guidelines on treatment of prostate cancer for patients. It is our considered opinion that this booklet is now among the very best basic introductions to prostate cancer management for any newly diagnosed patient and his family. … READ MORE …

Obesity and cancer (prostate cancer included): new ASCO policy statement

The American Society of Clinical Oncology (ASCO) has just published its first-ever policy statement on obesity and cancer, and is warning that “obesity could soon become the leading cause of cancer” here in America. … READ MORE …